Fennec Pharmaceuticals (FENC) Share-based Compensation (QoQ) (2010 - 2025)
Fennec Pharmaceuticals (FENC) Share-based Compensation (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,644.00% |
| Sep 30, 2025 | 107.28% |
| Jun 30, 2025 | -186.09% |
| Mar 31, 2025 | 121.22% |
| Dec 31, 2024 | -306.53% |
| Sep 30, 2024 | -13.16% |
| Jun 30, 2024 | 10,936.84% |
| Mar 31, 2024 | -97.78% |
| Dec 31, 2023 | -0.92% |
| Sep 30, 2023 | -65.99% |
| Jun 30, 2023 | 133.52% |
| Mar 31, 2023 | 3,400.00% |
| Dec 31, 2022 | -197.06% |
| Sep 30, 2022 | -2.86% |
| Jun 30, 2022 | -91.23% |
| Mar 31, 2022 | 115.56% |
| Dec 31, 2021 | -379.61% |
| Sep 30, 2021 | -30.84% |
| Dec 31, 2020 | -48.30% |
| Sep 30, 2020 | 5,795.24% |